Esperion Therapeutics reported $259.49M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 38.7B 2.18B
Biogen BIIB:US USD 6.28B 998M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Cytokinetics CYTK:US USD 610.73M 411.31M
Daiichi Sankyo 4568:JP JPY 143.28B 20.09B
Eli Lilly And LLY:US USD 15.89B 925.4M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Heron Therapeutics HRTX:US USD 149.23M 52K
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Moderna Inc MRNA:US USD 1.15B 384M
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Puma Biotechnology PBYI:US USD 97.99M 312K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
United Therapeutics UTHR:US USD 800M 0